Kevin Kee-Jong Hong | Professor
gachon university

Kee-Jong Hong (BS, Seoul National Univ; MS, Seoul National Univ; PhD, Texas Tech Univ) is currently a Professor at the Department of the Microbiology, Gachon University School of Medicine, Korea, and a Program Manager of Division for Health Security at Korea Advanced Research Project Agency for Health (ARPA-H) after finishing Korean National project for the mRNA Vaccine R&D, KmVAC(Korea mRNA Vaccine Initiative). He has conducted research and development related to the pandemic preparedness  including Influenza, Coronavirus, Ebola virus,  Nipah virus and Bioterrorism pathogens such as Anthrax, tularemia. He worked for the Korean Dsease Control and Prevention Agency (KCDA) for 10 years as a government officer, also worked as a director of the industrial research institutes including the Interpark BioConvergence (currently Gradient BioConvergence) and the NKmax for another 7 years before joining the Gachon University. He is  serving for the Korean Vaccine Society as a chair of publication committee, also serving for the Korean Society for  Zoonoses as  a vice president. In 2024, he was selected as a member of Scientific Advisory Committee for CEPI (Coalition for Epidemic Preparedness Innovations) and keeps working till 2027.